Introduction
The enzyme pyruvate kinase (PK) catalyzes the conversion of phosphoenolpyruvate to pyruvate, thereby generating adenosine triphosphate. 1 Erythrocyte PK is synthesized under the control of the PK-LR gene located on chromosome 1, and as many as 200 different mutations of this gene have been identified. 2 However, relatively few of these mutations give rise to the majority of cases of PK deficiency. 3 PK deficiency is the second most common hereditary variety of Coombs-negative, non-spherocytic hemolytic disease in the United States (glucose 6 phosphate dehydrogenase (G6PD) deficiency is first). 2 It is inherited in an autosomal recessive manner and most people with this deficiency are compound heterozygotes, meaning they inherited one mutant PK gene from their father, but a different PK mutation from their mother. 1 However, among tightly inbred communities, an identical mutation can be inherited from both parents. Such is the case for the Amish community, in which PK deficiency has been traced to a single immigrant couple. 4, 5 Beutler and Gelbart 6 estimated the overall prevalence of PK deficiency among Caucasians in the United States to be 1 case per 20 000 births.
In this study, we report four neonates with early and severe hyperbilirubinemia who were shown to have PK deficiency. In keeping with the American Academy of Pediatrics efforts to eliminate kernicterus, 7 we encourage clinicians to consider the diagnosis of PK deficiency in cases of early, Coombs-negative, non-spherocytic, hemolytic jaundice, and to aggressively manage such patients so as to avoid kernicterus. Moreover, we conclude that heterozygous (carrier) PK deficiency is unusually common in this particular polygamist community.
Cases
Intermountain Healthcare operates 18 hospitals offering obstetrical services in Western United States. During the 5-year period from 1 January 2004 through 31 December 2008, 153 830 live births were recorded at the Intermountain Healthcare hospitals. As we have previously reported, all neonates in Intermountain Healthcare hospitals receive a minimum of one bilirubin determination before hospital discharge. 8 In the four cases we now report, erythrocyte indices were obtained from blood samples run on a Beckman Coulter LH750 (Beckman Coulter, Fullerton, CA, USA). Reference ranges for erythrocyte indices of neonates at Intermountain Healthcare were published previously. 9 During the specified 5-year period, five neonates with PK deficiency were detected at Intermountain Healthcare (prevalence estimate, 1 case per 30 000 births). However, four of the five neonates were from one small town, a polygamist community, where the birth rate during this period was B200 per year. Thus, the minimal estimate for the prevalence of PK deficiency in that community was 1 case per 250 births. The four neonates with PK deficiency had many clinical and demographic features in common ( Table 1 ). All of them were term, Caucasian, born to polygamist families, and three of the four had one or two older siblings with PK deficiency. None had a parent with known PK deficiency. Two of the four cases had the same father. All four presented with visible jaundice on the first day after delivery.
Serial serum bilirubin concentrations of patients nos 1 and 3 are shown in Figure 1 .
None of the four jaundiced neonates received an exchange transfusion, but all were treated aggressively with phototherapy using multiple light sources. Patient no. 1 in Figure 1 was managed with guidance from the 2004 American Academy of Pediatrics (AAP) hyperbilirubinemia exchange transfusion guidelines. 7 Although the initial level was within the exchange transfusion range, the infant had not yet received phototherapy. After 6 h of intensive phototherapy, the bilirubin level had decreased to 20 mg per 100 ml. The subsequent bilirubin levels under phototherapy never exceeded the AAP-recommended exchange transfusion threshold for gestational age and risk factors.
All four affected neonates had normal mean corpuscular hemoglobin concentration measurements ranging from 32.3 to 34.2 g per 100 ml, [9] [10] [11] but markedly elevated red cell distribution width measurements (normal: 13 to 15%), 10, 12 and markedly elevated reticulocyte counts ( Table 1) . None of the four neonates developed recognizable bilirubin neurotoxicity. All had abnormally low PK activity detected (Lucille Packard Children's Hospital, Stanford, CA, USA), and all had blood transfusions during their first 2 years to treat anemia.
Discussion
Early, severe, hemolysis is a risk factor for kernicterus. [13] [14] [15] [16] Indeed, kernicterus has been reported in neonates who had hyperbilirubinemia associated with PK deficiency. 17 When hemolytic jaundice is diagnosed, such patients can generally be managed successfully using phototherapy or sometimes exchange transfusion. 1 However, when the diagnosis of hemolytic jaundice is missed, particularly when the patient is discharged from a short hospital stay, kernicterus or 'near-miss kernicterus' can result. 13, 17 PK deficiency is a rare cause of severe neonatal hemolytic jaundice, but nevertheless it is the second most common variety (next to G6PD deficiency) of non-spherocytic, Coombs-negative, hemolytic jaundice in the United States. 1, 5 We recently reported the problem of hereditary spherocytosis among neonates delivered at Intermountain Healthcare, 10 and pointed out that very high values for mean corpuscular hemoglobin concentration (>36 g per 100 ml) and red cell distribution width (>18%) can help clinicians identify neonates with this disorder. In contrast to hereditary spherocytosis, patients with PK deficiency have a normal mean corpuscular hemoglobin concentration; however, similar to those with hereditary spherocytosis they have an elevated red cell distribution width. The latter finding is based on marked reticulocytosis, as reticulocytes are larger than non-reticulocyte erythrocytes; therefore, reticulocytosis results in an elevated red cell distribution width. We suggest that when a neonate has early hemolytic jaundice and the Coombs test is negative, the mean corpuscular hemoglobin concentration is a useful screening tool; specifically, if it is elevated, hereditary spherocytosis is a likely diagnosis, but if it is normal, G6PD deficiency or PK deficiency should be considered. After this simple screen, a more definitive testing can be accomplished. For neonates with early jaundice, in addition to making the underlying diagnosis, considerable effort should be placed on bilirubin management, so as to avoid bilirubin neurotoxicity. [14] [15] [16] [17] We speculate that the American Academy of Pediatrics goal of preventing cases of kernicterus 7 can be furthered by improving awareness of PK deficiency and other causes of neonatal hemolytic jaundice. Diagnosing hemolytic diseases such as PK deficiency, hereditary spherocytosis and G6PD deficiency during the first days after birth can facilitate anticipatory, aggressive, bilirubin management. Moreover, early diagnosis of hemolytic disease can Abbreviations: DAT, direct antiglobulin test, or Coombs test, (reported as positive or negative); DOL, day of life when the highest bilirubin concentration was recorded; Fam Hx, family history of pyruvate kinase deficiency; GA, gestational age at birth (weeks); Hgb, blood hemoglobin concentration (g per 100 ml) at the time of highest recorded serum bilirubin; highest bili, highest total serum bilirubin (mg per 100 ml) recorded in the laboratory repository; LOS, length of initial hospital stay (days); MCHC, mean corpuscular hemoglobin concentration (g per 100 ml); ND, test not done; PK, pyruvate kinase; PRBC Tx, packed red blood cell transfusion; RDW, red cell distribution width (%), a quantitative assessment of erythrocyte anisocytosis; Retic, reticulocytes, given as a percentage of the erythrocyte concentration (%) and as an absolute number (reticulocytes per microliter blood); Sib, sibling. enable expectant management of chronic childhood anemia and low-grade jaundice, and bilirubin pigment cholelithiasis. 1 
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